EP
TARO
Eversept Partners’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-263,541
| Closed | -$11.2M | – | 85 |
|
|
2024
Q1 | $11.2M | Buy |
263,541
+7,553
| +3% | +$320K | 0.74% | 23 |
|
|
2023
Q4 | $10.7M | Buy |
255,988
+665
| +0.3% | +$27.8K | 0.94% | 22 |
|
|
2023
Q3 | $9.63M | Buy |
255,323
+5,037
| +2% | +$190K | 0.81% | 23 |
|
|
2023
Q2 | $9.49M | Buy |
250,286
+5,019
| +2% | +$190K | 0.79% | 26 |
|
|
2023
Q1 | $5.96M | Buy |
245,267
+19,805
| +9% | +$482K | 0.42% | 37 |
|
|
2022
Q4 | $6.55M | Buy |
225,462
+2,079
| +0.9% | +$60.4K | 0.57% | 34 |
|
|
2022
Q3 | $6.7M | Buy |
223,383
+2,993
| +1% | +$89.7K | 0.58% | 29 |
|
|
2022
Q2 | $7.97M | Buy |
220,390
+104
| +0% | +$3.76K | 0.57% | 34 |
|
|
2022
Q1 | $9.53M | Buy |
220,286
+39,135
| +22% | +$1.69M | 0.73% | 34 |
|
|
2021
Q4 | $9.08M | Buy |
181,151
+1,785
| +1% | +$89.4K | 0.58% | 36 |
|
|
2021
Q3 | $11.4M | Buy |
179,366
+5,117
| +3% | +$326K | 0.79% | 31 |
|
|
2021
Q2 | $12.5M | Buy |
174,249
+9,871
| +6% | +$710K | 0.84% | 25 |
|
|
2021
Q1 | $12.1M | Buy |
164,378
+12,122
| +8% | +$894K | 0.91% | 28 |
|
|
2020
Q4 | $11.2M | Buy |
152,256
+10,367
| +7% | +$761K | 1.31% | 22 |
|
|
2020
Q3 | $7.78M | Buy |
141,889
+36,720
| +35% | +$2.01M | 1.73% | 18 |
|
|
2020
Q2 | $6.99M | Buy |
105,169
+28,710
| +38% | +$1.91M | 0.96% | 23 |
|
|
2020
Q1 | $4.68M | Buy |
76,459
+71,506
| +1,444% | +$4.38M | 1.16% | 18 |
|
|
2019
Q4 | $436K | Buy |
+4,953
| New | +$436K | 0.08% | 65 |
|